Centre Directs States to Enforce Ban on Reuse of Single-Use Medical Devices
The Central government has directed all states and Union Territories to strictly enforce the prohibition on reusing single-use medical devices and disposable surgical items in public and private healthcare facilities. The directive, issued by the Directorate General of Health Services on October 16, highlights concerns over patient safety, infection prevention, regulatory compliance and reports that patients were charged the full price of equipment that had already been used.
The Directorate General of Health Services said it had received information that some private and corporate hospitals were sterilising and reusing medical devices labelled for one-time use. The practice was reportedly observed in specialised departments, including cardiology, nephrology, oncology, cardiothoracic and vascular surgery, and neurosurgery.
Under the directive, state and Union Territory authorities have been asked to maintain strict vigilance, inspect healthcare establishments and take appropriate action where violations are found. The government has also instructed hospitals to use medical devices and disposable surgical items according to the instructions and recommendations of their original manufacturers.
Why the Government Has Issued the Directive
Single-use medical devices are designed and labelled for use on one patient or during one procedure, as specified by the manufacturer. They are not necessarily designed or validated to be cleaned, sterilised and used again.
The DGHS has warned that reusing such devices can create risks even when they have undergone sterilisation. Inadequate cleaning or reprocessing may leave biological material behind, while repeated handling can affect the performance or reliability of certain devices.
The possible consequences include cross-infection, device malfunction, reduced performance and other complications during medical procedures. The directive identifies infection prevention and patient safety as key reasons for stricter enforcement.
The concern is particularly significant in procedures involving blood vessels, the heart, dialysis and complex surgery. Equipment used in these settings may come into contact with blood or internal tissues, making proper handling and compliance with manufacturer instructions essential.
Medical Devices Under Scrutiny
Reports on the directive have identified several categories of devices that may be affected by improper reuse. These include cardiac catheters, guidewires, balloon and ablation catheters, introducer sheaths and dialysis-related equipment such as dialysers and blood tubing.
Other items mentioned in reports include surgical staplers, laparoscopic trocars, orthopaedic drill bits, syringes and needles. These products have different designs and uses, but devices labelled for single use must be handled according to their specific instructions and applicable regulations.
The directive does not mean that every hospital has been found to be reusing these products. Rather, the health authorities have raised concerns about reported practices and instructed regulators to improve monitoring and enforcement across healthcare facilities.
Concerns Over Patient Billing
Alongside infection risks, the government has highlighted concerns about how patients are billed for medical consumables. The DGHS said there had been instances in which patients were allegedly charged the full cost of devices despite their reuse. In some cases, the cost was reportedly reimbursed by the relevant government authorities.
The issue raises questions about transparency in hospital billing and whether patients and public healthcare schemes receive accurate information about the medical items used during treatment.
Patients generally rely on healthcare providers to use appropriate equipment and maintain accurate records of treatment and charges. Where a device labelled for one-time use is reused, questions can arise about patient consent, safety standards and whether the billed amount reflects what was actually supplied and used.
The directive has therefore brought together two concerns: protecting patients from avoidable clinical risks and ensuring accountability in the use and billing of medical devices.
Laws and Regulations Cited by the DGHS
The DGHS has warned that the reuse of single-use medical devices may violate applicable provisions of the Drugs and Cosmetics Act, 1940, the Medical Devices Rules, 2017, and the Clinical Establishments Act, 2010. It has also referred to infection prevention and control protocols and biomedical waste management requirements.
These rules form part of the regulatory framework governing medical devices, healthcare establishments, safe clinical practices and the handling of medical waste. The specific legal consequences in an individual case will depend on the facts, the applicable provisions and the findings of the competent authorities.
The directive asks regulators to ensure compliance and take appropriate action in cases of non-compliance. It does not replace the need for inspections and evidence when determining whether a particular hospital has violated the law.
States and Drug Controllers Asked to Act
The letter was sent to senior state and Union Territory health officials, directors of health services, the Drug Controller General of India and state and Union Territory drug controllers.
These authorities have been asked to maintain vigilance, monitor healthcare establishments and ensure that the instructions are followed in both government and private facilities. Where violations are identified, they have been directed to take action under the relevant laws and regulations.
Effective enforcement will depend on how consistently inspections are carried out and how regulators respond to confirmed violations. Healthcare facilities will also need to ensure that their procurement, use, documentation and disposal practices comply with applicable rules.
Medical Device Industry Welcomes the Move
The Association of Indian Medical Device Industry has welcomed the directive, describing it as a step towards prioritising patient safety. Its forum coordinator, Rajiv Nath, said responsibility should rest with the establishment or person who reuses a device contrary to its labelled instructions.
Industry representatives have also called for regular inspections, traceable records of device use and disposal, staff awareness and clear accountability when equipment is reused improperly. Consistent enforcement, they say, will be important to ensuring that the directive has a practical effect.
What Patients Should Know
Patients can ask healthcare providers questions about the medical devices used during a procedure, particularly where a disposable item is involved. They can also request an explanation of relevant billing entries and raise concerns with the hospital administration if they suspect that equipment labelled for single use has been reused.
However, patients should not assume that a device has been reused solely because it has been sterilised or because its packaging is not immediately visible. Concerns should be addressed through the healthcare provider or appropriate regulatory authority, which can assess the circumstances.
The Centre's directive reinforces the requirement that devices labelled for one-time use must be used according to the manufacturer's instructions and applicable rules. Its impact will depend on effective monitoring, clear accountability and compliance across public and private healthcare facilities.
